Author: Andrew

Key data confirming Cantrixil kills ovarian cancer stem cells Unique action of inhibiting pro-survival mechanisms and promoting pro-death mechanisms US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ:NVGN) and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Meeting of the Society of Reproductive Investigation in San Francisco, CA. In both in vitro and in animal studies, Cantrixil, has proved highly effective at killing human ovarian stem (tumor-initiating) cells,…

Read More

LANGKAWAI, Malaysia, March 24, 2015 /PRNewswire/ — With the rapid development of science and technology, the intelligent commute is forming an inevitable trend of future transport. Airwheel has placed great emphasizes on the development of intelligent commuting products. Airwheel’s self balancing electric unicycle is going to start a revolution of eco-friendly commuters in 2015.

Read More

Rajendra Singh of India is named the 2015 Stockholm Water Prize Laureate, for his innovative water restoration efforts, improving water security in rural India, and for showing extraordinary courage and determination in his quest to improve the living conditions for those most in need.

Read More